Latest news
Health Canada review path for PrimeC: NeuroSense (NASDAQ: NRSN) - Stock TitanStock Titan · Thu, 06 Aug 2026 15:56:23 GMTNeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada - PR NewswirePR Newswire · Thu, 06 Aug 2026 15:29:00 GMTDeveloper to seek approval in Canada for ALS treatment aiding survival - ALS News TodayALS News Today · Tue, 28 Jul 2026 16:42:07 GMT